Tech Company Financing Transactions
Lyora Therapeutics Funding Round
Lyora Therapeutics, based in Providence, received $2.5 million from private investors.
Transaction Overview
Company Name
Announced On
7/15/2026
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Providence, RI Undisclosed
USA
Providence, RI Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Our approach uses genetic medicines to intervene at the root cause of disease with one-and-done treatment. Our science is based on decades of research on specific indications and the genetic medicine modalities we pursue. Our confidence in the science is supported by peer-reviewed research and validation by biopharma partners. Our assets demonstrate strong preclinical and/or clinical proof of principle for larger IRD patient populations, supporting the value creation and patient outcome for which we strive.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pamela Stetkiewicz
Co-Founder
Eric Pierce
Founder
Luk Vandenberghe
VP - Bus. Development
Rob Aboud
VP - R & D
Chris Wilson
Browse more venture capital transactions:
Prev: 7/15/2026: Rime Labs venture capital transaction
Next: 7/15/2026: AdvanCell venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs